Fetal growth is dependent on the placenta. The mechanisms by which peptide growth factors influence normal trophoblast growth and differentiation are central to this process, as are the pathways that regulate transport of nutrients across the trophoblast. In particular, the amino acid transport function of the placenta is dependent on its state of differentiation, and the mechanisms controlling transport at various stages of trophoblast differentiation have not been defined. One class of peptide growth factors, the insulin-like growth factors (IGF-1 and IGF-2), are likely to play major roles in regulating placental growth, development, and function, and the goals of this project are to elucidate the steps by which the IGFs influence trophoblast proliferation, differentiation, ad nutrient transport. For these studies, normal human trophoblasts and the b30 clone of the human BeWo choriocarcinoma cell line will be used as experimental model systems.
Four aims are proposed: 1. To characterize the expression of IGF receptors as a function of trophoblast differentiation. 2. To determine the polarity of receptor expression on maternal- and fetal-facing trophoblast membranes. 3. To define the effects of IGF-1 and IGF-2 on trophoblast proliferation, differentiation, and amino acid transport. 4. To investigate the roles of IGF binding proteins in modulating IGF activity in the differentiating trophoblast. The results of these studies will provide insights into the control of trophoblast growth and development, and will define the steps that are crucial for optimal maternal-fetal exchange of amino acids. These observations should enhance our understanding of the mechanisms regulating fetal growth and thereby contribute to improved strategies to ensure fetal well-being.

Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1996
Total Cost
Indirect Cost
Umayahara, Y; Billiard, J; Ji, C et al. (1999) CCAAT/enhancer-binding protein delta is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts. J Biol Chem 274:10609-17
Umayahara, Y; Ji, C; Centrella, M et al. (1997) CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone. J Biol Chem 272:31793-800
Mittanck, D W; Kim, S W; Rotwein, P (1997) Essential promoter elements are located within the 5' untranslated region of human insulin-like growth factor-I exon I. Mol Cell Endocrinol 126:153-63
Pike, L J; Casey, L (1996) Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J Biol Chem 271:26453-6
Rotwein, P; Bichell, D P; Kikuchi, K (1993) Multifactorial regulation of IGF-I gene expression. Mol Reprod Dev 35:358-63;discussion 363-4
Bichell, D P; Rotwein, P; McCarthy, T L (1993) Prostaglandin E2 rapidly stimulates insulin-like growth factor-I gene expression in primary rat osteoblast cultures: evidence for transcriptional control. Endocrinology 133:1020-8
Daughaday, W H; Trivedi, B (1992) Heterogeneity of serum peptides with immunoactivity detected by a radioimmunoassay for proinsulin-like growth factor-II E domain: description of a free E domain peptide in serum. J Clin Endocrinol Metab 75:641-5
Daughaday, W H; Trivedi, B (1992) Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 75:110-5
Kim, S W; Lajara, R; Rotwein, P (1991) Structure and function of a human insulin-like growth factor-I gene promoter. Mol Endocrinol 5:1964-72
Daughaday, W H; Trivedi, B (1991) Clinical aspects of GH binding proteins. Acta Endocrinol (Copenh) 124 Suppl 2:27-32

Showing the most recent 10 out of 12 publications